Selisistat

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSelisistat
Drug Alias Nameselisistatum司来司他塞利司他EX-527SEN-196 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent deacetylase sirtuin 1 inhibitors
TargetsNAD-dependent deacetylase sirtuin 1
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesElixir Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesElixir Pharmaceuticals IncSiena Biotech Spa
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A